Search

everythinglearnresearchcommunity

for

Search:↓

The study created 3D-printed pills that effectively release a hair loss treatment drug over 24 hours.

Stem cell therapies show promise for hair regrowth in alopecia areata but need more research for safety and effectiveness.

Biological factors are crucial for developing new hair restoration treatments.

Targeting gut microbiome and metabolome may help treat autoimmune skin diseases like alopecia areata.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

Baricitinib effectively and safely improves hair growth in patients with severe alopecia areata.

Experts created guidelines for who in Australia can get subsidized JAK inhibitor therapy for alopecia areata.

Baricitinib helped regrow hair in patients with severe alopecia areata after other treatments failed.

Upadacitinib improved multiple immune-related conditions in one patient.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

Topical ruxolitinib may help some skin conditions but needs more research for alopecia areata.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Abrocitinib may effectively treat stubborn alopecia universalis.

Abrocitinib helped a 14-year-old girl with severe alopecia areata regrow her hair significantly.

Upadacitinib effectively treats pyoderma gangrenosum.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Baricitinib is effective for severe alopecia areata but has some side effects.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

A new treatment called deucravacitinib helped a patient with severe hair loss grow their hair back quickly.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Baricitinib quickly improved severe alopecia areata, with almost total hair regrowth in three months.

Vitiligo treatment requires a personalized mix of therapies to restore skin color and improve life quality.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

Baricitinib may effectively treat nail changes in alopecia areata.